Down-regulation of IL-2 receptor α (CD25) characterizes human γδ-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12

Cancer Immunology, Immunotherapy

Volumn 50, Issue 11, 2002, Pages 625-637

  Guo, B L ^a   Hollmig, K A ^a   Lopez, R D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

IL 15; IL 2 receptor; Immunotherapy; T cells

Indexed keywords

CD2 ANTIGEN; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR; MITOGENIC AGENT; RECEPTOR SUBUNIT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; CELL SURVIVAL; CHO CELL; CONTROLLED STUDY; CYTOLOGY; HUMAN; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; T LYMPHOCYTE;

EID: 0035678634     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-001-0244-4     Document Type: Article

References (53)

1. Treatment of acute graft-versus-host disease with humanized anti-Tac: An antibody that binds to the interleukin-2 receptor
2. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
3. TCR γδ bearing lymphocyte clones with lymphokine activated killer activity against autologous leukemic cells
4. An innate view of gamma delta T cells
5. Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
6. Cytokine combinations: Therapeutic use in patients with advanced renal cell carcinoma
7. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
8. Endogenous production of interleukin-15 by activated monocytes is critical for optimal production of interferon-γ by natural killer cells
9. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gpl30
10. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming of IL-12 and tumor necrosis factor α production
11. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice
12. In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity
13. Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells
14. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α
15. IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens
16. Dissection of the combining site in a humanized anti-Tac antibody
17. CD2 regulates responsiveness of activated T cells to interleukin 12
18. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12
19. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
20. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15
21. Activation and function of gamma delta T cells
22. Regulation of interleukin-12 expression in human monocytes: Selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes
23. Adoptive cellular therapy
24. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice
25. + T cells
26. Activation and activation-driven death of human gamma/delta T cells
27. Activation and deactivation of cloned gamma/delta T cells
28. Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells
29. Gamma/delta and other unconventional T lymphocytes: What do they see and what do they do?
30. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation
31. The interleukin-2 receptor complex and signal transduction: Role of the beta-chain
32. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
33. CD2-mediated IL-12-dependent signals render human gamma-delta T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: Implications for the development of adoptive immunotherapy strategies
34. + T cells
35. Interleukin-2 receptor heterotrimer complex and intracellular signaling
36. Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors
37. + T lymphocytes, and NK cells
38. Treatment of malignant melanoma with interleukin-2
39. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex
40. A humanized antibody that binds to the interleukin 2 receptor
41. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer
42. Peripheral gamma delta T-cell populations in HIV-infected individuals with mycobacterial infection
43. Activation-induced death of mature T cells in the regulation of immune responses
44. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
45. The IL-2/IL-2 receptor system: A current overview
46. Interleukin 2 and its receptors: Recent advances and new immunological functions
47. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
48. T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma
49. Gamma delta T lymphocyte responses to HIV
50. Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections
51. Biological function and distribution of human interleukin-12 receptor beta chain
52. Cytokine regulation of IL-12 receptor beta2 expression: Differential effects on human T and NK cells
53. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation